Vera Therapeutics, Inc. (VERA)
40.33
+0.33
(+0.82%)
USD |
NASDAQ |
Apr 08, 16:00
40.35
+0.02
(+0.05%)
After-Hours: 20:00
Vera Therapeutics Shareholders Equity (Quarterly) : 604.52M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 636.37M |
| Syndax Pharmaceuticals, Inc. | 64.63M |
| Eli Lilly & Co. | 26.54B |
| Johnson & Johnson | 81.54B |
| United Therapeutics Corp. | 7.096B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 735.30M |
| Total Liabilities (Quarterly) | 130.78M |
| Debt to Equity Ratio | 0.1279 |
| Current Ratio | 13.54 |
| Net Debt Paydown Yield | -0.12% |